Given the central role of c-Myc in regulating metabolic pathways as well as cellular growth it is a commonly amplified oncogene in many hematologic and solid malignancies, including epithelial ovarian cancer [11, 12]. The gene discussed is MYC; the disease is ovarian carcinoma.